Bristol-Myers Squibb Company
SUBSTITUTED THIENOPYRROLES AS PAD4 INHIBITORS
Last updated:
Abstract:
The present invention provides compounds of formula (I) useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
7 Aug 2019
Issue date:
3 Mar 2022